Your browser doesn't support javascript.
loading
Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Health Care Setting.
Tyan, Kevin; Levin, Adriane; Avalos-Pacheco, Alejandra; Plana, Deborah; Rand, Eleanor A; Yang, Helen; Maliszewski, Laura E; Chylek, Lily A; Atta, Lyla; Tye, Mark A; Carmack, Mary M; Oglesby, N Synclaire; Burgin, Susan; Yu, Sherry H; LeBoeuf, Nicole R; Kemp, Jacqueline M.
Afiliação
  • Tyan K; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Levin A; Harvard Medical School, Boston, Massachusetts, USA.
  • Avalos-Pacheco A; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Plana D; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Rand EA; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Yang H; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Maliszewski LE; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Chylek LA; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Atta L; Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts, USA.
  • Tye MA; Harvard Ludwig Cancer Research Center and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
  • Carmack MM; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Oglesby NS; Harvard University Department of Systems Biology, Cambridge, Massachusetts, USA.
  • Burgin S; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Yu SH; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • LeBoeuf NR; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Kemp JM; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Open Forum Infect Dis ; 7(9): ofaa396, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32989420
ABSTRACT
Proper disinfection using adequate disinfecting agents will be necessary for infection control strategies against coronavirus disease 2019 (COVID-19). However, limited guidance exists on effective surface disinfectants or best practices for their use against severe acute respiratory coronavirus 2. We outlined a process of fully characterizing over 350 products on the Environmental Protection Agency List N, including pH, method of delivery, indication for equipment sterilization, and purchase availability. We then developed a streamlined set of guidelines to help rapidly evaluate and select suitable disinfectants from List N, including practicality, efficacy, safety, and cost/availability. This resource guides the evaluation of ideal disinfectants amidst practical considerations posed by the COVID-19 pandemic.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article